Showing 1 - 1 results of 1 for search 'The MMR-162 Study Group', query time: 0.01s Refine Results
  1. 1
    Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study

    Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study by The MMR-162 Study Group

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: